Pentameric ligand-gated ion channels (pLGICs) play a central role in intercellular communication in the nervous system and are involved in fundamental processes such as attention, learning, and memory. They are oligomeric protein assemblies that convert a chemical signal into an ion flux through the postsynaptic membrane, but the molecular mechanism of gating ions has remained elusive. Here, we present atomistic molecular dynamics simulations of the prokaryotic channels from Gloeobacter violaceus (GLIC) and Erwinia chrysanthemi (ELIC), whose crystal structures are thought to represent the active and the resting states of pLGICs, respectively, and of the eukaryotic glutamate-gated chloride channel from Caenorhabditis elegans (GluCl), whose openchannel structure was determined complexed with the positive allosteric modulator ivermectin. Structural observables extracted from the trajectories of GLIC and ELIC are used as progress variables to analyze the time evolution of GluCl, which was simulated in the absence of ivermectin starting from the structure with bound ivermectin. The trajectory of GluCl with ivermectin removed shows a sequence of structural events that couple agonist unbinding from the extracellular domain to ion-pore closing in the transmembrane domain. Based on these results, we propose a structural mechanism for the allosteric communication leading to deactivation/activation of the GluCl channel. This model of gating emphasizes the coupling between the quaternary twisting and the opening/closing of the ion pore and is likely to apply to other members of the pLGIC family.neurotransmitter receptors | chemo-electrical transduction | ion channel gating P entameric ligand-gated ion channels (pLGICs) mediate intercellular communication in the brain by converting a chemical signal, typically a local increase in the extracellular concentration of neurotransmitter, into an electrical signal, which is generated by an ion flux through the postsynaptic membrane (1). Understanding their function at an atomic level of detail is likely to be useful for the development of drug therapies against a range of disorders, including nicotine addiction, Alzheimer's disease, schizophrenia, and depression (2).pLGICs are oligomeric membrane proteins with a fivefold pseudosymmetry axis perpendicular to the membrane. Each subunit consists of an extracellular (EC) domain that contains the ligand-binding site and a transmembrane (TM) ion-pore domain. The agonist binding site is located at the boundary between subunits in the EC domain whereas the ion pore is formed by the transmembrane helices M2, which differentiate axial cationic and anionic channels (Fig. 1). An essential element of the mechanism is that these topologically distinct domains are allosterically coupled to each other (3, 4).Electrophysiology analysis of pLGICs first showed that the rapid delivery of agonist promotes fast opening of the channel whereas prolonged applications lead to a slow decrease of the response amplitude or "desensitization" (5). Several kineti...